MedicaidCoverageLow impact

Newsletter Vol. 27, No.05

Q: Who is affected by this change?

This affects New Jersey Medicaid Family Medicine, Internal Medicine, General Practice, Pain Management, Emergency Medicine providers in NJ on Medicaid plans.

New Jersey Medicaid·NJ · Family Medicine, Internal Medicine, General Practice +2 more·Pharmacy

Effective date

Not stated

We identified it

Jun 20, 2026

Days to comply

—

Summary

New Jersey has issued clinical guidance on naloxone (Narcan) prescribing for opioid overdose prevention. This is an educational bulletin encouraging providers to co-prescribe naloxone to high-risk patients and provides clinical criteria for identifying candidates.

Action Required

Action needed

No immediate billing changes required. This is educational guidance only. Providers should review naloxone prescribing criteria and consider co-prescribing for high-risk opioid patients, but no billing system updates are needed.

Related policy hubs

New Jersey Medicaid policies NJ policy changes Family Medicine Internal Medicine General Practice Pain Management Emergency Medicine